Private Placement

A new universal operating system and app store, QwikOS, launches to standardize humanoid robots, making them more accessible to developers and users.

As millions of solar panels near retirement, a Nevada facility gets the final go-ahead to turn a looming waste crisis into a source of valuable materials.

A new multi-target deal combines cutting-edge platforms to create next-gen cancer drugs, aiming to improve precision and patient outcomes.

A first-in-class antibody shows a strong safety profile, de-risking development and offering a new, targeted approach for severe autoimmune diseases.

With its lead asset TEC-001 targeting tough liver cancers, Teclison's presence at the ASCO GI Symposium puts its innovative approach in the spotlight.

With a new CEO who has three FDA-approved drugs to his name, Catalio-backed Rhapsogen is poised to redefine autoimmune disease treatment. Here's why.

EdgeCortix's SAKURA-II processor survives brutal radiation tests, paving the way for intelligent, real-time decision-making on satellites and the Moon.

With a top neurologist at the helm and a breakthrough platform, NanoMosaic aims to decentralize brain health diagnostics and reshape drug development.

A Boston-based startup claims its new metal is 3x stronger than competitors, poised to revolutionize aerospace, defense, and semiconductor manufacturing.

From tri-fold projectors for your EV to Roku TV integration, Aurzen's new devices at CES 2026 are pushing the boundaries of portable entertainment.

A groundbreaking Duke trial combines a novel device to lure cancer cells with targeted immunotherapy, offering real-time tracking and new hope for patients.

The cybersecurity firm becomes the first in its niche to reach Centaur status, highlighting a major industry shift from reactive fixes to automated validation.

NFL's Tetairoa McMillan, MLB's Devin Williams, and NBA's Jerami Grant join Waiākea, highlighting a trend of athletes backing brands with real impact.

At CES 2026, LIVALL unveils an AI-powered taillight and helmet ecosystem designed to eliminate blind spots and prevent collisions before they happen.

HighVista Strategies promotes three private equity experts to Partner, signaling a strategic reinforcement of its successful lower middle-market strategy.

CleanSpark boosts Bitcoin output by over 10% and pivots to AI data centers, all while helping stabilize the power grid in times of extreme demand.

With a new capital markets heavyweight on its board, Silver Viper Minerals signals a major push to advance its growing portfolio of precious metals projects.

With major clinical trials, including a novel approach for Alzheimer's, and key market access wins, MMI's Symani system is poised to redefine microsurgery.

With enrollment complete for three major trials, MediciNova braces for a transformative year with crucial data expected for its ALS and metabolic disease candidates.

Facing cautious investors, Silicom bets its future on next-gen tech like PQC and Edge. Can its bold growth plans overcome recent financial turbulence?